Testing effectiveness (Phase 2)Active Not RecruitingNCT06578559
What this trial is testing
Phase II Study of ctDNA-guided Encorafenib Plus Cetuximab Retreatment in Patients BRAF V600E Mutated mCRC
Who this might be right for
Colorectal Cancer
Gruppo Oncologico del Nord-Ovest 16